HomeBody MapPeptidesCalculator
Catalog3 refs

Cosyntropin

OtherResearch use only
Educational use only. Not medical advice. Verify all information with primary sources and a licensed clinician before use.
Half-life
3
Uses
250 mcg
Typical
Body Map
Loading 3D model…
Circulation
Overview

Cosyntropin (also known as Cortrosyn, ACTH 1-24, Tetracosactide) is a synthetic fragment of ACTH containing the first 24 amino acids that bind the melanocortin-2 receptor (MC2R) on adrenal cortex cells, triggering a rapid burst of cortisol synthesis and release. It is FDA-approved for diagnostic use as the standard dynamic endocrine test for adrenal insufficiency.

Primary Uses
Diagnostic testing for adrenal insufficiency (primary, secondary, or tertiary)
ACTH stimulation test to assess adrenal cortex function
Differentiating Addison disease from pituitary/hypothalamic causes of adrenal insufficiency
Protocol Reference
Dose
250 mcg IV/IM (standard diagnostic dose); 1 mcg IV (low-dose protocol)
Frequency
Single diagnostic dose
Route
IV · Intramuscular
Evidence
FDA Approved - Diagnostic use
Research References· 1
FDA Approved Labeling \- Prescribed dose ↗
PubMedPMID 87726811 mcg IV (low-dose)
Research Models
Human
Also in Other
Other
Abaloparatide
Osteoporosis treatment · Postmenopausal Osteoporosis
Other
ACE-031
Muscle Hypertrophy · Muscular Dystrophy
Other
ACTH (Cosyntropin)
Diagnostic tool to test adrenal gland function · Assess adrenal reserve
Other
Adrenocorticotropic hormone (ACTH)
adrenal insufficiency diagnosis · adrenal insufficiency treatment
Compare